Cite
Human Factors Study of a Newly Approved Epinephrine Prefilled syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis.
MLA
Moss, Ronald B., et al. “Human Factors Study of a Newly Approved Epinephrine Prefilled Syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) Including Anaphylaxis.” Journal of Allergy & Clinical Immunology, vol. 141, Feb. 2018, p. AB39. EBSCOhost, https://doi.org/10.1016/j.jaci.2017.12.126.
APA
Moss, R. B., Moll, T., Daniels, K., & Carlo, D. J. (2018). Human Factors Study of a Newly Approved Epinephrine Prefilled syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis. Journal of Allergy & Clinical Immunology, 141, AB39. https://doi.org/10.1016/j.jaci.2017.12.126
Chicago
Moss, Ronald B., Thomas Moll, Karen Daniels, and Dennis J. Carlo. 2018. “Human Factors Study of a Newly Approved Epinephrine Prefilled Syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) Including Anaphylaxis.” Journal of Allergy & Clinical Immunology 141 (February): AB39. doi:10.1016/j.jaci.2017.12.126.